title: Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol.
abstract: Sensing of dietary triacylglycerol in the proximal small intestine results in physiological, hormonal and behavioural responses. However, the exact physiological pathways linking intestinal fat sensing to food intake and the activation of brain circuits remain to be identified. In this study we examined the role of triacylglycerol digestion for intestinal fat sensing, and compared the effects of the triacylglycerol digestion products, fatty acids and 2-monoacylglycerol, on behavioural, hormonal and dopaminergic responses in behaving mice. Using an operant task in which mice are trained to self-administer lipid emulsions directly into the stomach, we show that inhibiting triacylglycerol digestion disrupts normal behaviour of self-administration in mice, indicating that fat sensing is conditional to digestion. When administered separately, both digestion products, 2-monoacylglycerol and fatty acids, were sensed by the mice, and self-administration patterns of fatty acids were affected by the fatty acid chain length. Peripheral plasma concentrations of the gut hormones GLP-1, GIP, PYY, CCK and insulin did not offer an explanation of the differing behavioural effects produced by 2-monoacylglycerol and fatty acids. However, combined with behavioural responses, striatal dopamine effluxes induced by gut infusions of oleic acid were significantly greater than those produced by equivalent infusions of 2-oleoylglycerol. Our data demonstrate recruitment of different signalling pathways by fatty acids and 2-monoacylglycerol, and suggest that the structural properties of fat rather than total caloric value determine intestinal sensing and the assignment of reward value to lipids.
authors: Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100, Copenhagen, Denmark; The John B. Pierce Laboratory, Yale University School of Medicine, 290 Congress Avenue, New Haven, CT, 06519, USA.
authors: Karen
authors: K
authors: Kleberg
authors: Anne Katrine
authors: AK
authors: Jacobsen
authors: Jozelia G
authors: JG
authors: Ferreira
authors: Johanne Agerlin
authors: JA
authors: Windeløv
authors: Jens F
authors: JF
authors: Rehfeld
authors: Jens Juul
authors: JJ
authors: Holst
authors: Ivan E
authors: IE
authors: de Araujo
authors: Harald S
authors: HS
authors: Hansen
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002755:Choice Behavior / Q000187:drug effects; D003216:Conditioning, Operant / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005227:Fatty Acids / Q000378:metabolism* / Q000494:pharmacology; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism*; D007783:Lactones / Q000494:pharmacology; D008049:Lipase / Q000037:antagonists & inhibitors; D008297:Male; D051379:Mice; D050178:Monoglycerides / Q000378:metabolism* / Q000494:pharmacology; D000077403:Orlistat; D012646:Self Administration; D014280:Triglycerides / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D005227:Fatty Acids; D007783:Lactones; D050178:Monoglycerides; D014280:Triglycerides; D000077403:Orlistat; D008049:Lipase
references: Nat Rev Drug Discov. 2012 Aug;11(8):603-19
references: 22790105
references: Am J Clin Nutr. 2011 Apr;93(4):703-11
references: 21310831
references: Int J Obes (Lond). 2013 Mar;37(3):375-81
references: 22546775
references: Trends Endocrinol Metab. 2013 Jul;24(7):332-41
references: 23567058
references: Annu Rev Nutr. 2013;33:1-21
references: 23642202
references: Science. 2013 Aug 16;341(6147):800-2
references: 23950538
references: Annu Rev Pharmacol Toxicol. 2014;54:407-34
references: 24160702
references: Pharmacol Res. 2014 Aug;86:18-25
references: 24681513
references: J Biol Chem. 1964 Dec;239:4081-90
references: 14247652
references: J Biol Chem. 2005 May 13;280(19):18667-82
references: 15774422
references: Cell Metab. 2008 Oct;8(4):281-8
references: 18840358
references: J Clin Endocrinol Metab. 2008 Oct;93(10):3995-8
references: 18647814
references: Cell Metab. 2008 Dec;8(6):447-9
references: 19041758
references: J Clin Endocrinol Metab. 2010 Feb;95(2):879-86
references: 19837920
references: Wiley Interdiscip Rev Syst Biol Med. 2010 Sep-Oct;2(5):577-93
references: 20836049
references: Vitam Horm. 2010;84:151-84
references: 21094899
references: FASEB J. 2011 Feb;25(2):765-74
references: 20959516
references: Physiol Behav. 2011 Sep 26;104(4):613-20
references: 21596051
references: Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E317-25
references: 21540445
references: J Clin Endocrinol Metab. 2011 Sep;96(9):E1409-17
references: 21778222
references: Handb Exp Pharmacol. 2012;(209):309-35
references: 22249821
references: Trends Endocrinol Metab. 2012 Feb;23(2):49-55
references: 22169756
references: J Physiol. 2012 Feb 15;590(4):953-72
references: 22219333
references: Nature. 2012 Mar 15;483(7389):350-4
references: 22343897
references: Trends Pharmacol Sci. 2012 Jul;33(7):374-81
references: 22560300
references: Biofactors. 2014 Jul-Aug;40(4):363-72
references: 24677570
references: Metabolism. 2012 Sep;61(9):1312-20
references: 22445513
references: J Biol Chem. 2000 Jun 2;275(22):16638-42
references: 10828060
references: J Pharm Sci. 2000 Aug;89(8):1073-84
references: 10906731
references: Neuron. 2001 Jun;30(3):819-28
references: 11430814
references: Am J Physiol Gastrointest Liver Physiol. 2003 May;284(5):G798-807
references: 12684211
references: J Clin Endocrinol Metab. 2003 Aug;88(8):3829-34
references: 12915676
references: Neuroimage. 2003 Aug;19(4):1709-15
references: 12948725
references: Prog Lipid Res. 2004 Mar;43(2):105-33
references: 14654090
references: Biochim Biophys Acta. 1988 Oct 14;962(3):308-16
references: 3167082
references: Clin Chem. 1998 May;44(5):991-1001
references: 9590372
references: Diabetes. 1998 Jul;47(7):1038-45
references: 9648826
references: Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R554-65
references: 21148477
references: Gastroenterology. 2011 Mar;140(3):903-12
references: 20955703